Author:
Brion Michel,Lambs Luc,Berthon Guy
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference54 articles.
1. D.R. Williams,Biofluid speciation models correlated with pharmaceutical activity, Proc. Sum. Conf. Comp. Simul., Boston Ms2, 792–797 (1984).
2. D.D. Perrin andH. Stünzi, Metal ions and Chelating agents in antiviral chemotherapy. InMetal Ions in Biological Systems, vol. 14, pp. 207–241 (Ed.H. Sigel). Marcel Dekker Inc., New York 1982.
3. P.M. May andR.A. Bulman, The present status of chelating agents in Medicine. InProgress in Medicinal Chemistry, vol. 20, pp. 225–336 (Ed.G.P. Ellis andG.B. West). Elsevier Science Publishers, New York 1983.
4. A. Cole, P.M. May andD.R. Williams,Metal binding by pharmaceuticals. Part 1. Cu(II) and Zn(II) interactions following ethambutol administration, Agents and Actions11, 296–305 (1981).
5. Z.X. Huang, P.M. May, K.M. Quinlan, D.R. Williams andA.M. Creighton,Metal binding by pharmaceuticals. Part 2. Interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICFR 159 and its inactive homologue ICRF 192, Agents and Actions12, 536–542 (1982).
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献